As of 2026-05-19, the Relative Valuation of STAAR Surgical Co (STAA) is (28.68) USD. This relative valuation is based on P/E multiples. With the latest stock price at 32.31 USD, the upside of STAAR Surgical Co based on Relative Valuation is -188.8%.
The range of the Relative Valuation is (26.58) - (30.78) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.4x - 20.3x | 18.1x |
| Forward P/E multiples | 16.1x - 18.9x | 17.2x |
| Fair Price | (26.58) - (30.78) | (28.68) |
| Upside | -182.3% - -195.3% | -188.8% |
| Date | P/E |
| 2026-05-18 | -19.88 |
| 2026-05-15 | -19.74 |
| 2026-05-14 | -19.70 |
| 2026-05-13 | -18.09 |
| 2026-05-12 | -17.34 |
| 2026-05-11 | -17.13 |
| 2026-05-08 | -16.43 |
| 2026-05-07 | -16.79 |
| 2026-05-06 | -17.08 |
| 2026-05-05 | -16.89 |
| 2026-05-04 | -16.80 |
| 2026-05-01 | -16.73 |
| 2026-04-30 | -16.22 |
| 2026-04-29 | -15.68 |
| 2026-04-28 | -16.43 |
| 2026-04-27 | -16.42 |
| 2026-04-24 | -15.80 |
| 2026-04-23 | -15.29 |
| 2026-04-22 | -15.26 |
| 2026-04-21 | -15.34 |
| 2026-04-20 | -15.71 |
| 2026-04-17 | -15.43 |
| 2026-04-16 | -15.15 |
| 2026-04-15 | -15.22 |
| 2026-04-14 | -15.03 |
| 2026-04-13 | -16.52 |
| 2026-04-10 | -16.27 |
| 2026-04-09 | -15.51 |
| 2026-04-08 | -12.85 |
| 2026-04-07 | -12.98 |
| 2026-04-06 | -12.90 |
| 2026-04-02 | -12.44 |
| 2026-04-01 | -11.90 |
| 2026-03-31 | -11.51 |
| 2026-03-30 | -11.29 |
| 2026-03-27 | -11.01 |
| 2026-03-26 | -11.47 |
| 2026-03-25 | -11.81 |
| 2026-03-24 | -11.67 |
| 2026-03-23 | -11.39 |
| 2026-03-20 | -10.78 |
| 2026-03-19 | -10.75 |
| 2026-03-18 | -11.43 |
| 2026-03-17 | -10.99 |
| 2026-03-16 | -11.13 |
| 2026-03-13 | -11.59 |
| 2026-03-12 | -11.32 |
| 2026-03-11 | -10.87 |
| 2026-03-10 | -10.60 |
| 2026-03-09 | -11.27 |